A review of the use of inhaled corticosteroids in pre-school wheezing
pdf

Keywords

Wheezing
Paediatric
Children

Abstract

 

 

https://doi.org/10.48037/mbmj.v6i9.250
pdf

References

Brand P, Baraldi E, Bisgaard H, et al. Definition, assessment and treatment of wheezing disorders in preschool children: an evidence based approach. Eur Respir J 2008;32:1096-110. Available from: https://doi.org/10.1183/09031936.00002108

Peckham C. Wheezy toddlers. MBMJ 2004;4(9):215-7. Available from: https://doi.org/10.48037/mbmj.v4i9.846

Newell S, Darling J. Lecture notes on Paediatrics, 8th ed. Blackwell Scientific: 2008

Kaditis AG, Winnie G, Syrogiannopoulos GA. Anti-inflammatory pharmacotherapy for wheezing in preschool children. Pediatr Pulmonol 2007;42:407-20. Available from: https://doi.org/10.1002/ppul.20591

Bhatt JM, Smyth AR. The management of pre-school wheeze. Paediatr Respir Rev 2011;12:70-7. Available from: https://doi.org/10.1016/j.prrv.2010.09.001

Hogg A, Simon C. Asthma in children. InnovAiT 2011;4:160-70. Available from: https://doi.org/10.1093/innovait/inq199

Bush A. The problem of preschool wheeze: new developments, new questions. Acta Medica Lituanica 2012;17:40-50. Available from: https://doi.org/10.2478/v10140-010-0006-8

Schultz ADS, Savenije OEM, Sly PD, Le Souef PN, Brand PLP. Acta Pediatrica 2009;99:56-60. Available from: https://doi.org/10.1111/j.1651-2227.2009.01508.x

van Aalderen W, Sprikkelman A. Inhaled corticosteroids in childhood asthma: the story continues. Eur J Pediatr 2011;170:709-18. Available from: https://doi.org/10.1007/s00431-010-1319-z

McKean MC, Ducharme F. Inhaled steroids for episodic viral wheeze of childhood. Cochrane Database of Systematic Reviews 2000. Available from: https://doi.org/10.1002/14651858.CD001107

Castro-Rodriguez JA, Rodrigo GJ. Efficacy of inhaled corticosteroids in infants and preschoolers with recurrent wheezing and asthma: a systematic review with meta-analysis. Paediatrics 2009;123:519-25. Available from: https://doi.org/10.1542/peds.2008-2867

Lenny W. Asthma in children. Medicine 2012;40:238-41

Jackson DJ, Sykes A, Mallia P, Johnston SL. Asthma exacerbations: origin, effect, and prevention. J Allergy Clin Immunol 2011;128(6):1165-74. Available from: https://doi.org/10.1016/j.jaci.2011.10.024

Castro-Rodriguez J, Holberg C, Wright A, Martinez F. A clinical index to define risk of asthma in young children with recurrent wheezing. Am J Respir Crit Care Med 2000;162:1403-6. Available from: https://doi.org/10.1164/ajrccm.162.4.9912111

Guilbert TW, Morgan WJ, Zeiger RS, et al. Long-term inhaled corticosteroids in preschool children at high risk for asthma. N Engl J Med 2006;354:1985-97. Available from: https://doi.org/10.1056/NEJMoa051378

Szefler SJ. Advances in pediatric asthma in 2010: addressing the major issues. J Allergy Clin Immunol 2010;127:102-15. Available from: https://doi.org/10.1016/j.jaci.2010.11.018

Szefler SJ. Advances in pediatric asthma in 2011: moving forward. J Allergy Clin Immunol 2011;129:60-8. Available from: https://doi.org/10.1016/j.jaci.2011.11.011

BTS/SIGN. British guideline on the management of asthma: quick reference guide. 2011. Available at: http://www.sign.ac.uk/pdf/qrg101.pdf (accessed 3 July 2012)

BMA, RPSoGB, RCPCH, Neonatal and Paediatric Pharmacists Group. British National Formulary for Children 2012-2013. 8th ed. London: BMJ Group; 2012

Ukena D, Biberger C, Steinijans V, et al. Ciclesonide is more effective than budesonide in the treatment of persistent asthma. Pulm Pharmacol Ther 2007;20(5):562-70. Available from: https://doi.org/10.1016/j.pupt.2006.05.007

Carlsen KCL, Stick S, Kamin W, et al The efficacy and safety of fluticasone propionate in very young children with persistent asthma symptoms. Respir Med 2005;99(11):1393-402. Available from: https://doi.org/10.1016/j.rmed.2005.04.008

McKay G, Reid J, Walters M. Lecture Notes on Clinical Pharmacology and Therapeutics. 8th ed. Wiley-Blackwell: 2010

Murray CS, Woodcock A, Langley SJ, Morris J, Custovic A. Secondary prevention of asthma by the use of inhaled fluticasone propionate in wheezy infants (IFWIN): double-blind, randomised, controlled study. Lancet 2006;368:754-62. Available from: https://doi.org/10.1016/S0140-6736(06)69285-4

Bisgaard H, Hermansen MN, Loland L, Halkjaer LB, Buchvald F. Intermittent inhaled corticosteroids in infants with episodic wheezing. N Engl J Med 2006;354(19):1998-2005. Available from: https://doi.org/10.1056/NEJMoa054692

NICE. Guidance on the use of inhaler systems (devices) in children under the age of 5 with chronic asthma. 2000. Available at: http://www.nice.org.uk/nicemedia/live/11400/32073/32073.pdf

Borton C. Which device in asthma? Patient UK 2010. Available at: http://www.patient.co.uk/doctor/Which-Device-in-Asthma.htm (accessed 17th July 2012)

Berg E, Madsen J, Bisgaard H. In vitro performance of three combinations of spacers and pressurized metered dose inhalers for treatment in children. Eur Respir J 1998;12(2):472-6. Available from: https://doi.org/10.1183/09031936.98.12020472

Barry PW, O’Callaghan C. Inhalational drug delivery from seven different spacer devices. Thorax 1996;51:835-40. Available from: https://doi.org/10.1136/thx.51.8.835

O’Callaghan C, Barry P. Spacer devices in the treatment of asthma. Br Med J 1997;314(7087):1061-2. Available from: https://doi.org/10.1136/bmj.314.7087.1061